Altogether, our findings indicate that endothelial PFKFB3 plays a critical role in IP angiogenesis and lesion progression, and that PFKFB3 inhibition is a promising approach to prevent plaque development and to reduce the complications of vein bypass grafting. The gene discussed is PFKFB3; the disease is incontinentia pigmenti.